Biocon

Biocon News

Biocon Biologics appoints Shreehas Tambe as Managing Director and CEO

According to the company, Shreehas Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.

December 5, 2022 14:24 IST

Adani Enterprises, Keystone Realtors, M&M Financial, Biocon, PVR, Can Fin Homes stocks in focus on F&O expiry

Indian benchmark indices are likely to open higher on F&O expiry amid firm global cues. SGX Nifty hinted at a…

November 24, 2022 07:12 IST

Biocon’s net profit declines 10% to Rs 168 crore in Q2FY23; Revenue up 26%

The strategic alliance with Serum Institute Life Sciences (SILS) for vaccines is on track for closure by Q3FY22, the company…

November 14, 2022 22:44 IST

Devastated to lose my husband, says Biocon founder Kiran Mazumdar-Shaw

John Shaw, who had served the Bengaluru-headquartered biopharmaceutical company as the Vice-Chairman and Non-Executive Director for over 22 years, passed…

Updated: October 25, 2022 13:30 IST

kiran shaw, kiran shaw husband, kiran mazumdar shaw husband, biocon ceo, biocon, john shaw, john shaw husband

‘John Shaw loved India, his passing a huge loss,’ say friends

To those who have seen the couple from outside, John Shaw seemed a pillar of support for Kiran Mazumdar in…

Updated: October 26, 2022 08:04 IST

Biocon Biologics, Biosimilars, Yoshindo Inc, Ustekinumab, bUstekinumab, health news, pharma news,

Biocon Biologics inks out-licensing agreement with Yoshindo Inc; To commercialise biosimilars in Japan

Reportedly, Biocon Biologics became the first company from India to commercialize a biosimilar in Japan, after its Insulin Glargine was…

October 17, 2022 10:57 IST

kiran shaw, biocon, jobs, education in india, yuva unstoppable

Never let gender come in the way of your ambitions, dream big: Kiran Mazumdar-Shaw at Yuva Unstoppable event

Shaw also emphasised on the importance of cleanliness and how it is a factor that will determine our country’s future…

Updated: October 3, 2022 16:35 IST

CBI files chargesheet in Biocon bribery case against five people

The bribe was allegedly for favourably recommending the file of Insulin Aspart Injection to the Subject Expert Committee (SEC) meeting…

August 25, 2022 17:07 IST

In view of this conclusion, the SAT quashed and set aside the Sebi order which had held Tambe guilty of insider trading and the corresponding penalty. The penalty of Rs 1 lakh for delayed disclosure under regulation 7(2)(a) was upheld.

SAT quashes insider trading charges against Biocon’s Shreehas Tambe

The appellant was also penalised for a sum of Rs 2 lakh.

August 4, 2022 00:10 IST

Biocon’s net profit rises 71 percent to Rs 144.4 crore in first quarter

In the corresponding quarter last year, the company posted a net profit of Rs 84.4 crore.

Updated: July 28, 2022 18:27 IST

Roshni Nadar India’s richest woman 2nd year in a row; Nykaa’s Falguni Nayar overtakes Kiran Mazumdar-Shaw

Roshni Nadar Malhotra, the chairperson of HCL Technologies, has retained the tag of the richest woman in India for the…

July 27, 2022 16:32 IST

Biocon Biologics receives EU GMP certification for its new biologics manufacturing facility in Bengaluru

According to the company’s press statement, the facility, spread across 340,000 square feet, will enhance the capabilities to manufacture drug…

July 5, 2022 19:11 IST

stocks to watch, stocks in focus, stocks in news, reliance ril

Reliance, Infosys, LIC, Biocon, Indian Oil, GR Infraprojects stocks in focus on monthly F&O expiry

Indian equity markets are likely to extend losses on Thursday as SGX Nifty signalled at a gap-down open for benchmark…

Updated: June 30, 2022 08:24 IST

Bajaj Finserv, Biocon among 39 stocks to hit 52-week low on BSE, 64 scrips at new highs

After a dismal start, benchmark indices recovered most of their losses on Wednesday as metals and some energy counters gathered…

June 29, 2022 12:52 IST

Expect regulatory nods for deal with Serum and Viatris to come by H2: Kiran Mazumdar-Shaw, chairperson, Biocon and Biocon Biologics

The vaccines alliance with Serum and our continued investment in R&D, adding products to our portfolio, opens up new growth…

May 4, 2022 06:00 IST

Biocon Biologics gets European Medicines Agency’s backing for Inpremzia

Inpremzia has been developed by Celerity Pharmaceuticals LLC using Biocon Biologics’ biosimilar insulin drug substance, Biocon Ltd said in a…

April 1, 2022 15:35 IST

University of Glasgow Names Research Centre After John Shaw and Kiran Mazumdar-Shaw

Mr John Shaw, who is a Glasgow University graduate, along with his wife Ms Kiran Mazumdar- Shaw had gifted $7.5…

March 29, 2022 16:00 IST

Expect Biocon to become fully integrated biosimilars firm post Viatris buy: Kiran Mazumdar-Shaw

Post the closure of the Viatris’ deal, Biocon Biologics will realise the full revenue and profits from its products, which…

March 24, 2022 03:50 IST

FE Pharma Summit, Sun Pharmaceutical, Zydus Cadila, Glenmark Pharmaceuticals, Biocon, DCGI

FE Pharma Summit to see industry titans swap ideas on steps to counter prickly challenges

The two day FE Pharma Summit 2022 is also an attempt to leverage the ability of the Indian pharma stakeholders…

Updated: March 23, 2022 15:05 IST

BBL (a subsidiary of BIOS) will acquire Viatris’ Biosimilar business to create a vertically integrated company in the Biologics segment.

Biocon Rating ‘Neutral’; Deal completes value chain in biologics

Valuation of Viatris’ biz is expensive; FY23/24e EPS up 3.4/15% with TP at Rs 385; ‘Neutral’ retained given limited upside

March 5, 2022 03:30 IST

Biocon share price falls 12% after deal with Viatris; should you buy, hold or sell? Here’s what brokerages say

Biocon’s recent acquisition of Viatris’ biosimilar assets offers significant long-term growth opportunities. However, a substantially higher debt to fund the…

March 2, 2022 11:18 IST